title: Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis.
authors.affiliation: Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
authors.forename: Horst
authors.initials: H
authors.lastname: Penkert
authors.affiliation: Division of Neuropathology, Institute of Pathology, Technische Universität München, Munich, Germany.
authors.forename: Claire
authors.initials: C
authors.lastname: Delbridge
authors.affiliation: Institute of Microbiology, Immunology, and Hygiene, Technische Universität München, Munich, Germany.
authors.forename: Nina
authors.initials: N
authors.lastname: Wantia
authors.affiliation: Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
authors.forename: Benedikt
authors.initials: B
authors.lastname: Wiestler
authors.affiliation: Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Korn
mesh_terms: D000074323:Alemtuzumab / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use*; D020314:Central Nervous System Fungal Infections / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy; D009617:Nocardia Infections / Q000150:complications* / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents; D000074322:Antineoplastic Agents, Immunological; D000074323:Alemtuzumab